The socioeconomic gradient in all-cause mortality for women with breast cancer: findings from the 1998 to 2006 National Cancer Data Base with follow-up through 2011

Annals of Epidemiology
Joe FeinglassAnthony Yang

Abstract

To analyze the association between socioeconomic status (SES) and all-cause mortality among women diagnosed with breast cancer before and after controlling for insurance status, race and ethnicity, stage, treatment modalities, and other demographic and hospital characteristics. Data analyzed included follow-up through 2011 for 582,396 patients diagnosed between 1998 and 2006 with ductal carcinoma in situ or invasive (stage I-IV) breast cancer from the National Cancer Data Base. SES was measured by grouping patients into six income and education-level ZIP code categories. Hierarchical Cox regression models were used to analyze SES survival differences. Five- and 10-year survival probabilities for the highest SES group were 87.8% and 71.5%, versus 79.5% and 61.5% for the lowest SES group. Controlling for all covariates reduced the highest-to-lowest SES hazard ratio from 1.69 (95% confidence interval: 1.64-1.74) to 1.27 (95% confidence interval: 1.24-1.31). Results were virtually identical in models that included comorbidity and invasive cancer patients only. Differences in insurance status, race, and stage at diagnosis are important components of SES disparities and explain about two-thirds of the initial SES survival disparity. ...Continue Reading

References

Jun 1, 1992·Journal of Clinical Epidemiology·R A DeyoM A Ciol
Aug 21, 2004·Health Affairs·J Michael McWilliamsJohn Z Ayanian
Mar 11, 2005·Health Affairs·Ichiro KawachiDean E Robinson
Aug 4, 2007·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Joe FeinglassDavid W Baker
Sep 13, 2007·Journal of the National Cancer Institute·Jessica D AlbanoMichael J Thun
May 28, 2010·Cancer Causes & Control : CCC·Carol DeSantisElizabeth Ward
Nov 23, 2012·The New England Journal of Medicine·Archie Bleyer, H Gilbert Welch
Aug 7, 2013·JAMA : the Journal of the American Medical Association·Jeffrey H SilberKevin R Fox
Jan 15, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Samir SonejiHarold C Sox

❮ Previous
Next ❯

Citations

Jan 26, 2016·Current Problems in Surgery·Christina A MinamiAnthony D Yang
May 1, 2016·Alcoholism, Clinical and Experimental Research·Kevin D ShieldJürgen Rehm
Apr 20, 2017·Journal of Burn Care & Research : Official Publication of the American Burn Association·Hala BedriLucy Wibbenmeyer
Apr 16, 2019·The Breast Journal·Luis A RibaTed A James
Sep 9, 2017·Breast Cancer Research and Treatment·Marie S DreyerLiliana E Pezzin
Nov 15, 2018·Frontiers in Oncology·Aracelis Z TorresCarlos Castillo-Salgado
Jul 5, 2019·Breast Cancer Research and Treatment·Steven S Coughlin
Aug 8, 2020·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Daniel WieseKevin A Henry
May 1, 2021·Cancer Control : Journal of the Moffitt Cancer Center·Nina AfsharRoger L Milne
Jun 16, 2021·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kirsten M M BeyerAnn B Nattinger
Jul 31, 2021·The Lancet Regional Health. Western Pacific·Fuh Yong WongUNKNOWN Joint Breast Cancer Registry collaborators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.